Search Within

Dazhi Liu

Formats
  1. Meeting Abstract (24)
  2. Journal Article (20)
  3. Editorial (1)
Groups
  1. Clinical Pharmacy Specialists (45)
  2. Department of Medicine (39)
  3. Solid Tumor Oncology Division (36)
  4. Thoracic Oncology (31)
  5. Hematology-Oncology Fellows (28)
  6. Weinberg Fellows (23)

More Groups

People
  1. Alexander Drilon (27)
  2. Bob Li (21)
  3. Michael Offin (13)
  4. Charles Rudin (9)
  5. Mark Kris (9)
  6. Christina Falcon (8)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (9)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Journal of Thoracic Oncology (7)
  3. Annals of Oncology (3)
  4. American Society of Clinical Oncology Educational Book (1)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Breast Cancer Research and Treatment (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (17)
  2. Elsevier Inc. (8)
  3. Oxford University Press (5)
  4. American Association for Cancer Research (2)
  5. Nature Publishing Group (2)
  6. Springer (2)

More Publishers

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Beware: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to "False" decreases in renal function
    Meeting Abstract

    Chen, M.; Harada, G.; Liu, D.; Dematteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Real-world landscape analysis of activating ERBB2/ERBB3 alterations in 107,561 tissue and plasma samples from patients with NSCLC
    Meeting Abstract

    Liu, D.; Jee, J.; Keller, R. B.; Schrock, A. B.; Drilon, A.; Oxnard, G. R.; Li, B. T.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of diverse targetable alterations in ERBB2 and ERBB3 in 93,465 non-small cell lung cancers (NSCLC)
    Meeting Abstract

    Liu, D.; Keller, R. B.; Heilmann, A. M.; Allen, J.; Oxnard, G. R.; Bazhenova, L.; Schrock, A. B.; Li, B. T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Central nervous system disease in patients with RET fusion-positive NSCLC treated with selpercatinib
    Journal Article

    Murciano-Goroff, Y. R.; Falcon, C. J.; Lin, S. T.; Chacko, C.; Grimaldi, G.; Liu, D.; Wilhelm, C.; Iasonos, A.; Drilon, A.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Central nervous system (CNS) outcomes and progression patterns in patients with RET fusion-positive lung cancers treated with selpercatinib
    Meeting Abstract

    Murciano-Goroff, Y. R.; Falcon, C. J.; Lin, S. T.; Dhawan, A.; Grimaldi, G.; Liu, D.; Wilhelm, C.; Thomas, R.; Iasonos, A.; Drilon, A. E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy
    Meeting Abstract

    Kalchiem-Dekel, O.; Falcon, C. J.; Bestvina, C. M.; Liu, D.; Kaplanis, L. A.; Wilhelm, C.; Eichholz, J.; Harada, G.; Wirth, L. J.; Lee, R. P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to TRK inhibitors
    Meeting Abstract

    Harada, G.; Choudhury, N. J.; Schram, A. M.; Rosen, E.; Murciano-Goroff, Y. R.; Falcon, C. J.; Wilhelm, C.; Kaplanis, L. A.; Liu, D.; Chang, J. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
    Meeting Abstract

    DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save